GenomeArc
GenomeArc is a biotech company specializing in clinical genetics and drug discovery, headquartered in Mississauga, Ontario. Founded in 2021, GenomeArc develops AI-integrated solutions for genetic diagnosis and genomic drug development, focusing on rare genetic disorders and pan-cancer applications. Their flagship product, the GenomeArc Horizon platform, offers ultra-fast variant interpretation, ACMG-guided diagnosis, carrier screening, and pharmacogenomic insights. The platform leverages AI, multi-omic data, and extensive clinical genomic databases to accelerate genomic medicine, enabling faster diagnoses and more precise therapeutic interventions for rare diseases and oncology. They aim to make efficient and accurate genome medicine technologies accessible globally.
GenomeArc
GenomeArc is a biotech company specializing in clinical genetics and drug discovery, headquartered in Mississauga, Ontario. Founded in 2021, GenomeArc develops AI-integrated solutions for genetic diagnosis and genomic drug development, focusing on rare genetic disorders and pan-cancer applications. Their flagship product, the GenomeArc Horizon platform, offers ultra-fast variant interpretation, ACMG-guided diagnosis, carrier screening, and pharmacogenomic insights. The platform leverages AI, multi-omic data, and extensive clinical genomic databases to accelerate genomic medicine, enabling faster diagnoses and more precise therapeutic interventions for rare diseases and oncology. They aim to make efficient and accurate genome medicine technologies accessible globally.